Hospital
Inspira Medical Center Woodbury, INC.
Inspira Medical Center Woodbury, INC. was paid $25.02M by Medicaid between Jan 2018 and Dec 2019, across 272 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoINSPIRA MEDICAL CENTER WOODBURY, INC.
WOODBURY, NJ 08096
WOODBURY, NJ 08096
33aNPI1184601288assigned 12/29/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.02M
24GClaims427,531
24DCodes billed272
24AFirst – last monthJan 2018 – Dec 2019
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#53 of 93
Median peer was paid$30.60M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 210,261 | $12.68M | |
| 2019 | 217,270 | $12.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 12,228 | 11,444 | $3.97M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 11,953 | 11,294 | $3.55M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 13% | 10,292 | 1,053 | $3.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 7,246 | 6,773 | $2.89M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 8.3% | 5,732 | 5,396 | $2.07M |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 4.7% | 5,892 | 4,860 | $1.18M |
| A0434 | Specialty care transport (sct) | 4.3% | 1,786 | 1,754 | $1.07M |
| G0378 | Hospital observation service, per hour | 3.6% | 2,583 | 2,285 | $890K |
| A0425 | Ground mileage, per statute mile | 2.9% | 16,032 | 13,764 | $714K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 3,143 | 2,996 | $562K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.1% | 3,982 | 1,969 | $285K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 701 | 699 | $264K |
260 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 7,010 | $257K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,347 | $228K |
| 59025 | Fetal non-stress test | <1% | 653 | $211K |
| A0433 | Advanced life support, level 2 (als 2) | <1% | 360 | $158K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,845 | $150K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 535 | $109K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 2,573 | $96K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,480 | $88K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 631 | $88K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,502 | $77K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,002 | $76K |
| 93017 | <1% | 175 | $75K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,043 | $71K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,489 | $69K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,041 | $66K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 472 | $63K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,650 | $62K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,749 | $61K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,492 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,858 | $58K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 932 | $57K |
| 94760 | <1% | 31,849 | $56K | |
| 76801 | <1% | 1,041 | $53K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 464 | $47K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 586 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,445 | $44K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,404 | $41K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 789 | $40K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,798 | $40K |
| 76830 | Ultrasound, transvaginal | <1% | 664 | $39K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,131 | $38K |
| 97010 | <1% | 3,139 | $37K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 501 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,099 | $36K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 258 | $35K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,180 | $35K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 115 | $34K |
| 97161 | <1% | 747 | $33K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 925 | $32K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 601 | $30K |
| OP710 | <1% | 1,479 | $30K | |
| 36000 | <1% | 4,668 | $30K | |
| OP279 | <1% | 4,159 | $30K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,376 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,278 | $27K |
| 84484 | <1% | 4,066 | $25K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 496 | $25K |
| 95806 | <1% | 25 | $24K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,302 | $24K |
| 93975 | <1% | 949 | $23K | |
| 80076 | <1% | 5,718 | $22K | |
| 81003 | <1% | 10,289 | $22K | |
| 85610 | <1% | 6,715 | $22K | |
| 93971 | <1% | 484 | $22K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,698 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,213 | $21K |
| 77066 | Tomosynthesis, mammo | <1% | 82 | $20K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,079 | $20K |
| 85730 | <1% | 6,196 | $19K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 590 | $19K |
| 73564 | <1% | 623 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,066 | $16K |
| J3490 | Unclassified drugs | <1% | 1,777 | $16K |
| 76642 | <1% | 254 | $16K | |
| 82962 | <1% | 2,476 | $15K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 885 | $15K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 192 | $15K |
| 86901 | <1% | 1,219 | $15K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 899 | $15K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 651 | $15K |
| J2704 | Injection, propofol, 10 mg | <1% | 897 | $15K |
| OP259 | <1% | 13,473 | $14K | |
| 73630 | <1% | 949 | $14K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,718 | $14K |
| 95819 | <1% | 79 | $14K | |
| 93970 | <1% | 194 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $13K |
| 81001 | <1% | 5,905 | $13K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,540 | $12K |
| 93041 | <1% | 2,378 | $12K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 623 | $12K |
| 80306 | <1% | 549 | $12K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 428 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 837 | $11K |
| 71250 | <1% | 229 | $11K | |
| 83690 | <1% | 4,097 | $11K | |
| 83735 | <1% | 2,596 | $10K | |
| 72110 | <1% | 312 | $10K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 94 | $10K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 49 | $10K |
| 83880 | <1% | 767 | $10K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,049 | $10K |
| 76813 | <1% | 80 | $9K | |
| 86850 | <1% | 896 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 892 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 892 | $9K |
| 80061 | Lipid panel | <1% | 652 | $9K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 37 | $9K |
| 76770 | <1% | 148 | $9K | |
| 73610 | <1% | 809 | $8K | |
| 73130 | <1% | 813 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,959 | $8K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,224 | $8K |
| 86900 | <1% | 1,217 | $7K | |
| 87186 | <1% | 1,036 | $7K | |
| 11043 | <1% | 44 | $7K | |
| 73030 | <1% | 711 | $7K | |
| 87070 | <1% | 1,127 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,424 | $7K |
| 17250 | <1% | 67 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 422 | $6K |
| 80329 | <1% | 1,474 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 190 | $6K |
| 87205 | <1% | 645 | $6K | |
| 76536 | <1% | 68 | $6K | |
| 73110 | <1% | 467 | $6K | |
| 84703 | <1% | 2,946 | $6K | |
| 82150 | <1% | 2,394 | $6K | |
| OP272 | <1% | 1,055 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,961 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 461 | $5K |
| 83605 | <1% | 810 | $5K | |
| 77065 | Tomosynthesis, mammo | <1% | 40 | $5K |
| 81025 | <1% | 3,635 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,972 | $5K |
| 96376 | <1% | 966 | $5K | |
| 85027 | <1% | 665 | $5K | |
| 87040 | <1% | 884 | $4K | |
| 88304 | <1% | 165 | $4K | |
| 90715 | <1% | 575 | $4K | |
| 97597 | <1% | 28 | $4K | |
| 82550 | <1% | 718 | $4K | |
| 84702 | <1% | 998 | $4K | |
| 97116 | <1% | 429 | $4K | |
| 72100 | <1% | 332 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 50 | $4K |
| 80320 | <1% | 2,484 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,581 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 129 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 107 | $3K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 445 | $3K |
| 70486 | <1% | 149 | $3K | |
| 73620 | <1% | 227 | $3K | |
| 73502 | <1% | 257 | $3K | |
| 84100 | <1% | 643 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 895 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,015 | $3K |
| 85379 | <1% | 1,002 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 961 | $3K |
| 73562 | <1% | 324 | $3K | |
| OP250 | <1% | 1,706 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,077 | $3K |
| 97162 | <1% | 93 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 80 | $3K |
| 74022 | <1% | 345 | $3K | |
| OP270 | <1% | 104 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 520 | $2K |
| 85018 | <1% | 377 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 493 | $2K |
| 80165 | <1% | 246 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,269 | $2K |
| 80178 | <1% | 153 | $2K | |
| 87147 | <1% | 664 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 730 | $2K |
| 82375 | <1% | 245 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 26 | $2K |
| 82803 | <1% | 199 | $2K | |
| 83050 | <1% | 227 | $2K | |
| 72131 | <1% | 101 | $2K | |
| 82948 | <1% | 172 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 269 | $2K |
| 73080 | <1% | 159 | $1K | |
| 87077 | <1% | 291 | $1K | |
| 72050 | <1% | 49 | $1K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 538 | $1K |
| 74018 | <1% | 147 | $1K | |
| 82553 | <1% | 111 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 390 | $1K |
| 94664 | <1% | 14 | $1K | |
| OP450 | <1% | 175 | $1K | |
| 94729 | <1% | 28 | $1K | |
| 94727 | <1% | 27 | $1K | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 349 | $1K |
| J2760 | Injection, phentolamine mesylate, up to 5 mg | <1% | 117 | $1K |
| J1815 | Injection, insulin, per 5 units | <1% | 21 | $1K |
| 97802 | <1% | 13 | $990.11 | |
| 73590 | <1% | 112 | $916.05 | |
| 82607 | <1% | 33 | $867.86 | |
| 97164 | <1% | 26 | $858.55 | |
| 87081 | <1% | 227 | $798.38 | |
| 87807 | <1% | 325 | $733.61 | |
| A4311 | Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) | <1% | 97 | $629.97 |
| 73120 | <1% | 75 | $611.01 | |
| 85652 | <1% | 373 | $602.26 | |
| 51702 | <1% | 27 | $591.89 | |
| 82746 | <1% | 15 | $562.24 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 2,278 | $548.69 |
| 72040 | <1% | 52 | $541.19 | |
| 85380 | <1% | 74 | $533.37 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 100 | $533.03 |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 12 | $518.25 |
| 89220 | <1% | 111 | $512.43 | |
| 86804 | <1% | 27 | $510.50 | |
| 73090 | <1% | 71 | $501.32 | |
| 86592 | <1% | 249 | $465.71 | |
| 72070 | <1% | 12 | $449.11 | |
| 73560 | <1% | 48 | $427.26 | |
| 36600 | <1% | 182 | $423.08 | |
| 87340 | <1% | 79 | $421.24 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 634 | $406.74 |
| 87071 | <1% | 124 | $359.21 | |
| OP637 | <1% | 1,856 | $344.44 | |
| 86140 | <1% | 202 | $340.22 | |
| 83021 | <1% | 14 | $328.51 | |
| 86403 | <1% | 41 | $311.07 | |
| 87088 | <1% | 216 | $307.94 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 213 | $305.31 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 53 | $296.64 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 39 | $282.40 |
| 86308 | <1% | 232 | $280.61 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 258 | $279.91 |
| 86703 | <1% | 14 | $274.14 | |
| 86787 | <1% | 17 | $246.54 | |
| 97165 | <1% | 12 | $215.72 | |
| A4344 | Indwelling catheter, foley type, two-way, all silicone or polyurethane, each | <1% | 12 | $196.65 |
| 71101 | <1% | 24 | $196.17 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 13 | $185.34 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,003 | $184.98 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 27 | $179.08 |
| 85008 | <1% | 593 | $170.25 | |
| 84550 | <1% | 14 | $169.11 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 31 | $166.09 |
| 87420 | <1% | 92 | $153.99 | |
| 85007 | <1% | 214 | $153.55 | |
| 87430 | <1% | 113 | $152.06 | |
| 86762 | <1% | 16 | $148.78 | |
| OP258 | <1% | 142 | $138.72 | |
| 73600 | <1% | 30 | $136.65 | |
| 87073 | <1% | 60 | $128.15 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 16 | $115.78 |
| 86618 | <1% | 12 | $100.26 | |
| 84436 | <1% | 12 | $86.80 | |
| 29530 | <1% | 12 | $85.30 | |
| 82247 | <1% | 18 | $80.68 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 253 | $73.27 |
| 73140 | <1% | 30 | $62.99 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 71 | $27.89 |
| 82330 | <1% | 12 | $18.46 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 37 | $17.17 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 19 | $10.68 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 15 | $9.93 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 26 | $5.05 |
| 82248 | <1% | 12 | $4.50 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 28 | $4.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 31 | $4.00 |
| 73552 | 0% | 12 | $0.00 | |
| 88342 | 0% | 12 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 17 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAHAM, JOHN (VICE PRESIDENT COO)
| Provider | Location | Paid |
|---|---|---|
| Inspira Medical Center Woodbury, INC. | Woodbury, NJ | $24K |
| Windham Urology Group PC | Brooklyn, CT | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.